儿童实体器官移植后疫苗可预防感染的住院发生率及相关疾病负担、死亡与费用
移植时年龄小于2岁及接受肺、心、肠或多器官移植与住院风险升高正相关。
要点
- 儿童实体器官移植后5年内15.6%因疫苗可预防感染住院,发生率最高达一般人群87倍。
- 移植时年龄<2岁及接受肺、心、肠或多器官移植与感染住院风险升高相关。
核心结论
- 儿童实体器官移植受者移植后5年内疫苗可预防感染住院率超过15%,发生率达一般人群的87倍。
- 这些感染带来显著的疾病负担、死亡和费用,支持对所有移植候选者和受者进行免疫接种。
研究设计与样本
- 2004年1月1日至2011年12月31日开展的多中心回顾性队列研究,通过儿科健康信息系统纳入移植时小于18岁的实体器官移植受者,每例随访5年(研究期间死亡者除外)。
主要发现
- 6980例受者中3819例(54.7%)为男孩,移植时平均(SD)年龄8(6.2)岁。
- 1092例(15.6%)共发生1471例疫苗可预防感染,其中187例(12.7%)发生于移植住院期间。
- 所有感染的病死率为1.7%。
- 排除移植住院期间发生的感染后,1257例中213例(17.0%)因疫苗可预防感染住院并需要重症监护。
- 多变量分析显示,移植时年龄小于2岁及接受肺、心、肠或多器官移植与疫苗可预防感染住院风险升高正相关。
关键数值与推荐
- 疫苗可预防感染住院发生率最高达一般人群的87倍。
临床怎么用
- 应确保所有实体器官移植候选者和受者完成免疫接种,以降低移植后疫苗可预防感染住院风险。
- 对移植时年龄小于2岁及接受肺、心、肠或多器官移植的患儿应特别关注疫苗可预防感染的预防和监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Pediatric transplant recipients are at risk for vaccine-preventable infections owing to immunosuppression, suboptimal response to vaccines before and after transplant, and potential underimmunization if transplant occurred early in life. However, the incidence and burden of illness from vaccine-preventable infections in this population is unknown. OBJECTIVES: To evaluate in pediatric solid organ transplant recipients the number of hospitalizations for vaccine-preventable infections in the first 5 years after transplant and to determine the associated morbidity, mortality, and costs. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study from January 1, 2004, to December 31, 2011, with 5 years of follow-up per participant (unless they died during the study period). The participants of this multicenter study through the Pediatric Health Information System were solid organ transplant recipients who were younger than 18 years at the time of transplant. Analysis began in July 2017. EXPOSURES: Transplant. MAIN OUTCOMES AND MEASURES: Hospitalizations for a vaccine-preventable infection during the first 5 years after transplant were ascertained using International Classification of Diseases, Ninth Revision, and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, clinical modification diagnosis codes. Data were collected on clinical care, outcomes, and costs during these hospitalizations. RESULTS: Of 6980 transplant recipients identified, there were 3819 boys (54.7%), and the mean (SD) age at transplant was 8 (6.2) years. Overall, 1092 patients (15.6%) had a total of 1471 cases of vaccine-preventable infections. There were 187 of 1471 cases (12.7%) that occurred during transplant hospitalization. The case fatality rate was 1.7% for all infections. Excluding infections that occurred during transplant hospitalization (when all patients go to the intensive care unit), 213 of 1257 patients (17.0%) were hospitalized with a vaccine-preventable infection requiring intensive care. In multivariable analysis, age younger than 2 years at time of transplant and receipt of a lung, heart, intestine, or multivisceral organ were positively associated with increased risk of a hospitalization from a vaccine-preventable infection.Transplant hospitalizations complicated by vaccine-preventable infections were $120 498 more expensive (median cost) than transplant hospitalizations not complicated by vaccine-preventable infections. CONCLUSIONS AND RELEVANCE: Hospitalization for vaccine-preventable infections occurred in more than 15% of solid organ transplant recipients in the first 5 years after transplant at a rate of up to 87 times higher than in the general population. There was significant morbidity, mortality, and costs from these infections, demonstrating the importance of immunizing all transplant candidates and recipients. Further research on improving immunization delivery, preventing nosocomial infections, and monitoring response to vaccines in the transplant population is needed.
引用
- Feldman AG, Beaty BL, Curtis D, et al. Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs. JAMA Pediatr. 2019. PMID: 30640369. doi:10.1001/jamapediatrics.2018.4954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。